The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Imolieve 2 mg orodispersible tablets

Clonmel Healthcare LtdPA0126/305/001

Main Information

Trade NameImolieve 2 mg orodispersible tablets
Active SubstancesLoperamide hydrochloride
Dosage FormOrodispersible tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/305/001

Group Information

ATC CodeA07DA Antipropulsives
A07DA03 loperamide


License statusAuthorised
Licence Issued27/09/2019
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back